Carlo Riccardo Rossi
Carlo Riccardo Rossi is an expert in Oncology at Azienda Ospedaliera di Padova (Italy). As of July 2026, ScienceLeadR ranks Carlo Riccardo Rossi in the top 1% of experts worldwide for Melanoma and Skin Neoplasms. Carlo Riccardo Rossi has authored 213 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 573 (community average: 125). How the SLR is computed.
LeadR Profile
Oncology
Subspecialties: Public Health - Dermatology - Geriatrics
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1999 - 2026
Number : 213
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Diabetes and melanoma: Impact on prognosis and healthcare costs. PMID 42390309 — diabetes mellitus, registries, sexually transmitted diseases, health care costs, melanoma, cohort studies, skin diseases, prognosis, diabetes mellitus, type 2, melanoma, cutaneous malignant | J Eur Acad Dermatol Venereol | 2026 | 0 |
| Impact of comorbidities on survival in melanoma patients. PMID 41291616 — comorbidity, melanoma, neoplasms, cohort studies | BMC Cancer | 2025 | 0 |
| Healthcare costs of cutaneous melanoma according to comorbidity patterns: a population-based study from the Regional Cancer Registry of the Veneto Region. PMID 41179802 — registries, comorbidity, health care costs, melanoma, neoplasms, cohort studies, public health | Front Public Health | 2025 | 0 |
| A real-world direct cost associated with a 4-year postdiagnosis follow-up in a population-based cohort of patients with melanoma by clinical-pathological characteristics. PMID 40163012 — health care costs, growth, melanoma, therapeutics, health expenditures | Melanoma Res | 2025 | 0 |
| Excision margins and prognosis in cutaneous melanoma: retrospective population-based cohort study. PMID 40331740 — margins of excision, melanoma, surgical procedures, operative, cohort studies, prognosis | BJS Open | 2025 | 0 |
Clinical Studies 1
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
LeadR Networks
Main global connection map